Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
BMC Cancer
|
July 29, 2010
Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation
Kamil Gotfryd, Galina Skladchikova, Eugene A Lepekhin, et al.
Anti-Cancer Drugs
|
September 26, 2007
Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects
Seema V Garde, André J Forté, Michael Ge, et al.
Journal of Cell Science
|
February 13, 2002
NCAM regulates cell motility
Søren Prag, Eugene A Lepekhin, Kateryna Kolkova, et al.
Toxicology and Applied Pharmacology
|
May 29, 2002
Automated in vitro screening of teratogens
Peter S Walmod, Anton Berezin, Helen C Gallagher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin
Fabio Pastorino, Daniela Di Paolo, Federica Piccardi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
BMC Cancer
|
July 29, 2010
Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation
Kamil Gotfryd, Galina Skladchikova, Eugene A Lepekhin, et al.
Anti-Cancer Drugs
|
September 26, 2007
Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects
Seema V Garde, André J Forté, Michael Ge, et al.
Journal of Cell Science
|
February 13, 2002
NCAM regulates cell motility
Søren Prag, Eugene A Lepekhin, Kateryna Kolkova, et al.
Toxicology and Applied Pharmacology
|
May 29, 2002
Automated in vitro screening of teratogens
Peter S Walmod, Anton Berezin, Helen C Gallagher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin
Fabio Pastorino, Daniela Di Paolo, Federica Piccardi, et al.
Page
of 1